Skip to main content
India Glycols Ltd logo

India Glycols Ltd — Investor Relations & Filings

Ticker · INDIAGLYCO ISIN · INE560A01023 LEI · 3358002YVDZUMPZLN823 BSE.NS Manufacturing
Open in API
Filings indexed 1,575 across all filing types
Latest filing 2023-12-20 Regulatory Filings
Country IN India
Listing BSE.NS INDIAGLYCO

About India Glycols Ltd

https://www.indiaglycols.com/

India Glycols Ltd is a pioneer in the manufacturing of green technology-based chemicals. The company specializes in producing bio-based glycols, including monoethylene glycol (MEG), diethylene glycol (DEG), and triethylene glycol (TEG), utilizing renewable feedstock such as molasses. Its product portfolio extends to ethylene oxide derivatives, surfactants, and performance chemicals tailored for diverse applications in textiles, personal care, and oil and gas. Additionally, the company operates in the natural gums, industrial gases, and nutraceuticals sectors. IGL is recognized for its commitment to sustainable chemistry, being the first globally to commercialize the production of ethylene oxide and glycols from bio-ethanol. Its operations also include the production of extra neutral alcohol and high-quality spirits, serving both industrial and consumer markets with a focus on eco-friendly processes.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges regarding the rescheduling of an analyst/investor meeting. It explicitly states that no unpublished price sensitive information will be shared and is primarily an announcement about the timing change of a meeting. The document length is only 1664 characters, which is quite short and does not contain any financial data, report content, or detailed presentation material. It is not a financial report, earnings release, or investor presentation itself, but rather a regulatory announcement about a meeting schedule change. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-12-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges regarding the rescheduling of an analyst/investor meeting. It explicitly states that no unpublished price sensitive information will be shared and is primarily an announcement about the timing change of a meeting. There is no financial data, report content, or detailed presentation included. The document length is only 1664 characters, which is quite short and fits the pattern of an announcement rather than a full report or transcript. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance-related disclosures that do not fit other categories.
2023-12-20 English
PFA update on rescheduling of Analyst/Investor meeting scheduled on 21st December, 2023
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges regarding the rescheduling of an analyst/investor meeting. It explicitly states that no unpublished price sensitive information will be shared and is primarily an announcement about the timing change of a meeting. The document length is only 1664 characters, which is quite short and does not contain any financial data, report content, or detailed presentation material. It does not contain any financial statements or substantive financial analysis. Therefore, it is not an investor presentation or financial report but rather a regulatory announcement about a meeting schedule change. This fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-12-20 English
This has reference to our intimation dated 18th December 2023 regarding Analyst/Investor Meeting with the Management of the Company scheduled for 21st December 2023 at 4:00 PM. Due to ....
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges regarding the rescheduling of an analyst/investor meeting. It explicitly states that no unpublished price sensitive information will be shared and is primarily an announcement about the timing change of a meeting. There is no financial data, report content, or detailed presentation included. The document length is only 1664 characters, which is quite short and fits the pattern of an announcement rather than a full report or transcript. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2023-12-20 English
Intimation of Analyst/Investor meeting
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) disclosing the schedule of analyst and institutional investor meetings. It references Regulation 30 of the SEBI Listing Regulations, which pertains to disclosure obligations. The content is about informing the exchanges and public about upcoming investor meetings and explicitly states that no unpublished price sensitive information will be shared. There are no financial statements, no detailed financial data, no audit information, or report attachments. The document is an announcement of an event related to investor relations rather than a financial report or detailed presentation. Therefore, it fits best under the category of Investor Presentation (IP) as it relates to investor meetings and presentations, but since it is only an intimation of the meeting schedule and not the presentation itself, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a general regulatory announcement and disclosure under SEBI regulations without substantive financial content or presentation materials attached.
2023-12-18 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges disclosing the schedule of analyst and institutional investor meetings. It references Regulation 30 of the SEBI Listing Regulations, which pertains to disclosure obligations for listed companies. The content is an announcement of upcoming investor meetings and explicitly states that no unpublished price sensitive information will be shared. The document is short (2079 characters) and does not contain any financial data, results, or detailed reports. It is an update on investor relations activities rather than a financial report or earnings release. Therefore, it fits best under the category of Investor Presentation (IP) or a related category. However, since it is only an intimation of meetings and not a detailed presentation, it is more appropriate to classify it as a Regulatory Filing (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories. Confidence is high due to clear regulatory reference and document content.
2023-12-18 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.